Spire Wealth Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$33.5M Buy
27,938
+364
+1% +$372K 1.01% 13
2026
Q1
$25.4M Sell
27,574
-145
-0.5% -$147K 0.87% 18
2025
Q4
$29.8M Buy
27,719
+592
+2% +$566K 1% 12
2025
Q3
$20.7M Sell
27,127
-138
-0.5% -$103K 0.7% 29
2025
Q2
$21.1M Sell
27,265
-6,530
-19% -$5.07M 0.76% 27
2025
Q1
$27.9M Buy
33,795
+848
+3% +$706K 0.89% 16
2024
Q4
$25.4M Buy
32,947
+449
+1% +$372K 0.79% 21
2024
Q3
$28.8M Buy
32,498
+1,266
+4% +$1.14M 0.97% 18
2024
Q2
$28.3M Sell
31,232
-225
-0.7% -$180K 1% 18
2024
Q1
$40.8M Buy
31,457
+378
+1% +$269K 0.74% 31
2023
Q4
$19.5M Buy
31,079
+2,200
+8% +$1.28M 0.65% 30
2023
Q3
$15.5M Sell
28,879
-5,579
-16% -$2.87M 0.59% 34
2023
Q2
$16.2M Buy
34,458
+194
+0.6% +$81.4K 0.6% 30
2023
Q1
$11.8M Buy
34,264
+1,358
+4% +$458K 0.46% 43
2022
Q4
$12M Buy
32,906
+4,319
+15% +$1.53M 0.68% 28
2022
Q3
$9.24M Sell
28,587
-9,907
-26% -$3.14M 0.56% 39
2022
Q2
$12.5M Buy
38,494
+28,932
+303% +$8.68M 0.51% 44
2022
Q1
$2.74M Sell
9,562
-5,884
-38% -$1.51M 0.07% 227
2021
Q4
$4.28M Buy
15,446
+6,961
+82% +$1.76M 0.1% 192
2021
Q3
$1.96M Buy
8,485
+897
+12% +$221K 0.05% 286
2021
Q2
$1.74M Sell
7,588
-6,878
-48% -$1.38M 0.05% 318
2021
Q1
$2.7M Buy
+14,466
New +$2.83M 0.07% 230

Other funds holding LLY

Spire Wealth Management's LLY Position: Q2 2026 in Review

Spire Wealth Management increased its Eli Lilly (LLY) stake by 1.3% in Q2 2026, buying an estimated $372K and bringing the position to 27,938 shares worth $33.5M. The position accounts for 1.01% of the portfolio, ranked #13.

Spire Wealth Management first reported a position in LLY in Q1 2021 and has held it in 22 quarters since. The position peaked at $40.8M in Q1 2024. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Spire Wealth Management held 27,938 shares of Eli Lilly worth $33.5M as of Q2 2026.
  • Spire Wealth Management bought 364 Eli Lilly shares in Q2 2026, an estimated $372K.
  • Eli Lilly made up 1.01% of Spire Wealth Management's portfolio in Q2 2026, its #13 holding.
  • Spire Wealth Management first reported a position in Eli Lilly in Q1 2021 and has held it in 22 quarters since.
  • Spire Wealth Management's Eli Lilly position peaked at $40.8M in Q1 2024.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Spire Wealth Management's 13F filing for Q2 2026, filed 15 Jul 2026.